Search results
Results from the WOW.Com Content Network
These drugs interfere with the normal cycling of microtubule depolymerization and repolymerization in small diameter sensory fibers to create sensory dominant neuropathy. Sensory side effects include paresthesias, dysesthesias, numbness, altered proprioception, and loss of dexterity in fingers and toes. Motor and autonomic symptoms are less ...
Neck-tongue syndrome (NTS), which was first recorded in 1980, [1] is a rare disorder characterized by neck pain with or without tingling and numbness of the tongue on the same side as the neck pain. [2] Sharp lateral movement of the head triggers the pain, usually lasting from a few seconds to a few minutes. Headaches may occur with the onset ...
These agents are associated with fewer neuromotor side effects and a lower risk of developing tardive dyskinesia. [ 37 ] Studies have tested the use of melatonin , high dosage vitamins , and different antioxidants in concurrence with antipsychotic drugs (often used to treat schizophrenia ) as a way of preventing and treating tardive dyskinesia.
Cerebrovascular accident (stroke); Myocardial infarction (heart attack); Cardiomyopathy; Congestive heart failure; Bradycardia; Dysphoria; Hallucinations; Feelings of ...
The new drug is intended for treatment of moderate to severe acute pain in adults. Common Pain Reliever Could Cause Medical Complications In Some People Over 65, Study Suggests
Peripheral neuropathy may be classified according to the number and distribution of nerves affected (mononeuropathy, mononeuritis multiplex, or polyneuropathy), the type of nerve fiber predominantly affected (motor, sensory, autonomic), or the process affecting the nerves; e.g., inflammation (), compression (compression neuropathy), chemotherapy ([[chemother completion.
While we’re totally judgment-free when it comes to that choice, some may not want to go under the needle or This Miracle Lip Balm Will Help Plump Lips Without Unpleasant Side Effects Skip to ...
These side effects are serious and some of them are permanent, and many remain a crucial concern for companies and healthcare professionals and substantial efforts are being encouraged to reduce the potential risks for future antipsychotics through more clinical trials and drug development.